RVNC
Revance Therapeutics, Inc.
RVNC
RVNC
Delisted
RVNC was delisted on the 5th of February, 2025.
115 hedge funds and large institutions have $1.25B invested in Revance Therapeutics, Inc. in 2017 Q4 according to their latest regulatory filings, with 38 funds opening new positions, 45 increasing their positions, 19 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
35% more funds holding
Funds holding: 85 → 115 (+30)
41% less call options, than puts
Call options by funds: $9.89M | Put options by funds: $16.9M
Holders
115
Holding in Top 10
3
Calls
$9.89M
Puts
$16.9M
Top Buyers
| 1 | +$44M | |
| 2 | +$39.3M | |
| 3 | +$35.8M | |
| 4 |
AllianceBernstein
Nashville,
Tennessee
|
+$31.7M |
| 5 |
Jennison Associates
New York
|
+$17.2M |
Top Sellers
| 1 | -$39.2M | |
| 2 | -$26.8M | |
| 3 | -$14.3M | |
| 4 |
Goldman Sachs
New York
|
-$5.66M |
| 5 |
WRF
Waddell & Reed Financial
Overland Park,
Kansas
|
-$5.03M |